Tranzyme Pharma has successfully completed its chemistry-based drug discovery collaboration with Bristol-Myers Squibb and has transferred compounds, across multiple drug targets, to BMS for further development. Tranzyme has the option to pursue select collaboration targets for internal development.   The collaboration, established in December 2009, utilized Tranzyme’s chemistry technology, Macrocyclic Template Chemistry (MATCH), for the discovery of novel active macrocycles against a range...